Three new NASBA-approved live webinar courses on Health Savings Accounts are now available from Roy Ramthun, who led the U.S. Treasury's implementation of HSAs...
Demand for the best HVAC business loans for bad credit in 2025 is climbing nationwide as ROK Financial expands no credit check financing programs, offering heating and cooling contractors faster access to working capital amid rising costs and tighter credit standards.
Demand for the best HVAC business loans for bad credit in 2025 is climbing nationwide as ROK Financial expands no credit check financing programs, offering heating and cooling contractors faster access to working capital amid rising costs and tighter credit standards.
The 12 institutional-quality assets span 3.18M SF across strategic logistics hubs nationwide
WASHINGTON, Aug. 14, 2025 /PRNewswire/ -- JLL's Capital Markets group announced today that it...
TORTOLA, British Virgin Islands, Aug. 7, 2025 /PRNewswire/ -- Worldwide Stablecoin Payment Network (WSPN), a leading stablecoin infrastructure provider with its flagship product stablecoin WUSD,...
The patented Carbon Stablecoin Framework powers a new era of scalable, regulated and sustainable cross-border payments and FX.
SINGAPORE, July 30, 2025 /PRNewswire/ -- Alpha Ladder...
From finances to business ownership, survey highlights opportunity to close critical information gap and help unlock greater newcomer financial confidence
TORONTO, July 28, 2025 /CNW/...
TOKYO, July 28, 2025 /PRNewswire/ -- Quantum Solutions Co., Ltd. (2338.T) and its affiliates (the "Quantum Solutions' Group" or "Quantum Solutions"), a Tokyo Stock Exchange-listed company,...
NEW YORK and MAINZ, GERMANY, July 25, 2025 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for the companies’ LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY® LP.8.1) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The adaptation is based on the recommendation from the EMA’s Emergency Task Force (ETF) to update COVID-19 vaccines to target the LP.8.1 variant for the 2025-2026 season. The ETF stated that “targeting LP.8.1 will help maintain the effectiveness of the vaccines as SARS-CoV-2 continues to evolve.”2
NetworkNewsWire Editorial Coverage
NEW YORK, July 21, 2025 /PRNewswire/ -- Gold's remarkable surge beyond $3,300 per ounce (all figures are in U.S. dollars unless otherwise noted)...
NetworkNewsWire Editorial Coverage
NEW YORK, July 21, 2025 /PRNewswire/ -- Gold's remarkable surge beyond $3,300 per ounce (all figures are in U.S. dollars unless otherwise noted)...